Contrast-induced nephropathy (CIN) is a leading cause of hospital-acquired acute kidney
injury (AKI). N-acetylcysteine (NAC) was proposed as an effective preventative measure. As …

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures. It
is the third most common cause of hospital acquired acute renal injury. As there are currently …

Background Conflicting results have been obtained in trials that have evaluated the
prophylactic efficacy of N‐acetylcysteine (NAC) pretreatment in the prevention of contrast …

The nephroprotective role of N-acetylcysteine (NAC) against contrast-induced nephropathy
(CIN) in patients undergoing peripheral arterial angiography remains unclear. A total of 40 …

It is unclear whether N-acetylcysteine is useful in preventing contrast-induced nephropathy
in patients undergoing coronary angiography. Because of different inclusion and exclusion …

Background Contrast-induced nephropathy (CIN) is one of the common causes of acute
renal insufficiency after contrast procedures. Whether intravenous N-acetylcysteine (NAC) is …

Abstract Background N-Acetylcysteine (NAC) is reported to have potential for preventing of
contrast-induced nephropathy (CIN) in patients undergoing coronary angiography …

Background There have been a myriad of studies investigating the effectiveness of N-
acetylcysteine (NAC) in the prevention of contrast induced nephropathy (CIN) in patients …

Background Aceltylcysteine has been evaluated in several small trials as a means of
reducing the risk of contrast-induced nephropathy (CIN), however systematic reviews of …

Background Contrast-induced nephropathy is an important cause of acute renal failure. We
assess the efficacy of acetylcysteine for prevention of contrast-induced nephropathy among …